Compare ESI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESI | ICLR |
|---|---|---|
| Founded | 1922 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.3B |
| IPO Year | 2014 | 2001 |
| Metric | ESI | ICLR |
|---|---|---|
| Price | $36.44 | $158.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $35.56 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 4.1M | 504.0K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $2,551,200,000.00 | N/A |
| Revenue This Year | $21.24 | N/A |
| Revenue Next Year | $7.34 | N/A |
| P/E Ratio | $156.57 | ★ $12.91 |
| Revenue Growth | ★ 3.84 | N/A |
| 52 Week Low | $22.86 | $66.57 |
| 52 Week High | $49.25 | $203.91 |
| Indicator | ESI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 42.29 |
| Support Level | $36.41 | $150.86 |
| Resistance Level | $37.32 | $183.11 |
| Average True Range (ATR) | 1.31 | 6.05 |
| MACD | 0.13 | -1.19 |
| Stochastic Oscillator | 67.09 | 7.57 |
Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.